Medical Weight Loss for Springfield, Massachusetts Residents

Springfield, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Springfield through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in Massachusetts: patients in Springfield see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Springfield Residents Choose New Hope Weight Loss

New Hope was designed around the way Springfield residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Springfield is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

Your zip code in Springfield, Massachusetts does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout Downtown, Forest Park, and the greater Pioneer Valley. From your first question to your ongoing refills, the whole Massachusetts experience is built to feel personal, private, and genuinely supported.

Telehealth lets you skip the commute entirely, so the time you would have spent driving across Springfield goes straight into starting your program. Tirzepatide, which shares its active ingredient with Mounjaro and Zepbound, starts at $233 per month for Springfield patients and is billed apart from the $119 visit. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Springfield and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Springfield

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Springfield address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Springfield

How does someone in Springfield access New Hope Weight Loss?

Access from Springfield is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Springfield, Massachusetts through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Springfield residents?

A clinic visit is never part of it for Springfield. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Springfield inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Springfield patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Springfield residents are charged no distance surcharge.

What areas of Springfield do you serve?

We serve patients from across Springfield by telehealth, including Downtown, Forest Park, and the greater Pioneer Valley.

Is bilingual (Spanish) telehealth care available for Springfield patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Springfield patients.

Springfield Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Springfield, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.